Brian Druker

Discovers, develops, manufactures and delivers human therapeutics

Functions as a College/University

Functions as a College/University

Operates an independent private foundation dedicated to advancing the medical sciences by supporting research and other scientific and educational activities

Develops and commercializes molecular diagnostics for oncology applications

Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer

Operates as a clinical-stage biopharmaceutical company that develops therapies to address cancer

Part of Oregon Health & Science University, OHSU Knight Cancer Institute is a comprehensive cancer center specializing in a broad spectrum of cancers, including breast, colon, leukemia, liver, lung, lymphoma, pancreatic, prostate, and pediatric cancers. The company is based in OR. The institute offers advanced, personalized treatment options such as immunotherapy, chemotherapy, radiation, surgery, targeted therapies, CAR T-cell therapy, and tumor-infiltrating lymphocyte (TIL) therapy. It operates multiple locations across Portland and surrounding areas, including community clinics, the OHSU Breast Center, and OHSU Doernbecher Children’s Hospital, emphasizing accessible, team-based, and patient-centered care. The institute provides patient and family support services, genetic counseling, cancer screening programs, and navigation assistance. Research and innovation are central to its mission, with numerous research projects and clinical trials underway annually, focusing on precision cancer medicine, early detection, and translational research. It hosts specialized research resources and collaborates with national and international partners. The institute also offers training programs for healthcare professionals and engages in community outreach through grants and public programs.